GLP3

Retatrutide is a next-generation, multi-receptor peptide studied for its powerful effects on weight regulation, appetite control, and metabolic optimization. As a triple agonist targeting GLP-1, GIP, and glucagon receptors, it represents one of the most advanced compounds in research focused on body fat reduction and metabolic efficiency.

Retatrutide works across multiple metabolic pathways simultaneously, making it uniquely positioned in research exploring comprehensive weight management mechanisms.

Key research areas include:

• Significant reduction in body weight and fat mass

• Strong appetite suppression and satiety signaling

• Enhanced energy expenditure and metabolic rate

• Improved insulin sensitivity and glucose regulation

• Support for sustained fat loss and metabolic health

  
  

  Unlike single-pathway compounds, Retatrutide activates three key receptors:

  • GLP-1: Regulates appetite and slows gastric emptying

  • GIP: Enhances insulin response and nutrient utilization

  • Glucagon: Increases energy expenditure and fat metabolism

  This combination creates a powerful environment for simultaneous fat loss and metabolic optimization.

  
  

  Research involving Retatrutide often highlights:

  • Substantial reductions in total body fat

  • Improvements in waist circumference and visceral fat markers

  • Support for lean mass retention during fat loss phases All products are intended for research use only. They are not intended for human or animal consumption, for use in any diagnostic or therapeutic procedures.

Please note that lyophilized powder may break loose during shipping; this is a normal occurrence and does not affect the quality of the research product. Please note that quantities may vary between batches.